 |
 |
 |
 |
 |
| |
18-months |
12-months |
12-months |
|
| |
ended |
ended |
ended |
Year ended |
| |
31
Dec |
31
Dec |
31 Dec |
30 June |
| |
2004 |
2004 |
2003 |
2003 |
| |
US$ |
US$ |
US$ |
US$ |
| |
million |
million |
million |
million |
| INCOME STATEMENT |
|
|
|
|
| Revenue |
2 229 |
1 370 |
1 016 |
827 |
| Operating expenses |
(1 901) |
(1 153) |
(886) |
(695) |
| Net operating profit |
328 |
217 |
130 |
132 |
| Net financing costs |
(71) |
(43) |
(34) |
(27) |
| Income from equity-accounted |
|
|
|
|
| investments |
(2) |
|
(5) |
|
| Profit before taxation |
255 |
174 |
91 |
105 |
| Taxation |
(77) |
(54) |
(20) |
(25) |
| Minority interest |
(11) |
(14) |
3 |
|
| Net profit attributable to ordinary |
|
|
|
|
| shareholders |
167 |
106 |
74 |
80 |
| Attributable earnings per share |
|
|
|
|
| (US cents) |
56 |
36 |
25 |
27 |
| Headline earnings |
180 |
122 |
77 |
87 |
| Headline earnings per share (US cents) |
60 |
41 |
26 |
30 |
| BALANCE SHEET |
|
|
|
|
| Assets |
|
|
|
|
| Non-current assets |
|
|
|
|
| Property, plant and equipment |
1 499 |
|
1 257 |
1 105 |
| Biological assets |
5 |
|
5 |
4 |
| Intangible assets |
13 |
|
14 |
13 |
| Goodwill |
(9) |
|
(12) |
(11) |
| Investments in associates and |
|
|
|
|
| joint ventures |
17 |
|
19 |
16 |
| Deferred taxation |
11 |
|
10 |
21 |
| Financial assets |
50 |
|
57 |
37 |
| Current assets |
|
|
|
|
| Cash and cash equivalents |
222 |
|
153 |
130 |
| Other |
486 |
|
416 |
361 |
| Total assets |
2 294 |
|
1 919 |
1 676 |
| Equity and liabilities |
|
|
|
|
| Shareholders funds |
947 |
|
758 |
659 |
| Minority interest |
196 |
|
185 |
160 |
| Non-current liabilities |
|
|
|
|
| Interest-bearing borrowings |
412 |
|
351 |
377 |
| Deferred taxation and provisions |
367 |
|
239 |
242 |
| Current liabilities |
|
|
|
|
| Interest-bearing borrowings |
148 |
|
192 |
72 |
| Other |
224 |
|
194 |
166 |
| Total equity and liabilities |
2 294 |
|
1 919 |
1 676 |
| Net debt |
338 |
|
390 |
320 |
| CASH FLOW STATEMENT |
|
|
|
|
| Cash available from operations |
284 |
225 |
170 |
86 |
| Proceeds on disposal of assets |
42 |
8 |
17 |
5 |
| Investments |
|
|
|
|
| Acquisition of subsidiary |
|
|
49 |
41 |
| Acquisition of joint ventures |
|
|
|
|
| and associates |
|
(2) |
(16) |
(4) |
| Capital expenditure |
(247) |
(139) |
(179) |
(154) |
| Other |
(28) |
(12) |
24 |
(1) |
| Net cash inflow |
51 |
80 |
65 |
(27) |